NEURO / SIGNALING RESEARCH

Ipamorelin

A selective growth-hormone secretagogue studied for its effects on growth hormone release.

For research purposes only — not for human or veterinary use. This page is educational and not medical advice.
Ipamorelin
NOT FDA-APPROVED FOR ANY USE

What is Ipamorelin?

Ipamorelin is a selective growth-hormone secretagogue, meaning it stimulates the release of growth hormone from the pituitary gland. It is noted in research for its relative selectivity compared to older secretagogues, with less effect on cortisol and other hormones in preclinical studies.

Areas of Research Interest

  • Growth hormone secretion pathway studies
  • Selectivity research compared to other secretagogues
  • Body composition and recovery studies in animal models
  • Sleep quality research

Regulatory Status

Ipamorelin is not FDA-approved for any human or veterinary use. It has not completed human clinical trials establishing safety or efficacy, and is classified as a research chemical intended solely for laboratory research.

Educational information only. This content is not intended to diagnose, treat, cure, or prevent any disease, and does not provide guidance on personal use, dosing, or administration. Consult qualified professionals and current regulatory sources for guidance specific to your situation.